MEET BRIDGE MEDICINES

Bridge Medicines biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Our mission is to move breakthrough research to the patient by bringing the best in modern drug discovery to the service of academic medicine.

LEARN MORE
OUR MODEL
OUR TEAM

RECENT NEWS

OUR PARTNERS

Loading...

WHAT ARE WE WORKING ON NOW?

Gain insight into transformational ideas and breakthrough research nurtured in our current pipeline.

OUR PIPELINE